Novartis Pharmaceuticals and Sandoz Products
Add-on therapy for symptomatic treatment of stable angina
Trangit MR
Trimetazidine Hydrochloride
Add-on therapy for symptomatic treatment of stable angina
Antianginal
Sandoz
All forms of depression, Panic attacks, Pavor nocturnus (night or sleep terror)
TOFRANIL
Imipramine Hydrochloride
All forms of depression, Panic attacks, Pavor nocturnus (night or sleep terror)
Antidepressant
Sandoz
Epilepsy, Acute mania; maintenance treatment of bipolar affective disorders, Alcohol withdrawal syndrome, Trigeminal neuralgia, Idiopathic glossopharyngeal neuralgia, Painful diabetic neuropathy, Diabetes insipidus centralis. Prescription drug
Tegretol
Carbamazepine
Epilepsy, Acute mania; maintenance treatment of bipolar affective disorders, Alcohol withdrawal syndrome, Trigeminal neuralgia, Idiopathic glossopharyngeal neuralgia, Painful diabetic neuropathy, Diabetes insipidus centralis. Prescription drug
Novartis Pharmaceuticals
Tegretol 2% Syrup
Carbamazepine
Epilepsy, Acute mania; maintenance treatment of bipolar affective disorders, Alcohol withdrawal syndrome, Trigeminal neuralgia, Idiopathic glossopharyngeal neuralgia, Painful diabetic neuropathy, Diabetes insipidus centralis. Prescription drug
Novartis Pharmaceuticals
Tegretol CR
Carbamazepine
Epilepsy, Acute mania; maintenance treatment of bipolar affective disorders, Alcohol withdrawal syndrome, Trigeminal neuralgia, Idiopathic glossopharyngeal neuralgia, Painful diabetic neuropathy, Diabetes insipidus centralis. Prescription drug
Novartis Pharmaceuticals
Epilepsy: partial seizures and generalized tonic-clonic seizures. Prescription drug
Trileptal
Oxcarbazepine
Epilepsy: partial seizures and generalized tonic-clonic seizures. Prescription drug
Novartis Pharmaceuticals
Trileptal Oral Suspension
Oxcarbazepine
Epilepsy: partial seizures and generalized tonic-clonic seizures. Prescription drug
Novartis Pharmaceuticals
Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) Antineoplastic agents
Tasigna
Nilotinib
Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) Antineoplastic agents
Novartis Pharmaceuticals
Treatment of patients with HER2 overexpressing breast cancer in combination with: Capecitabine, for treatment of patients with advanced or metastatic breast cancer who have progressed on prior trastuzumab therapy in the metastatic setting, HR+ mets BC
Tykerb
Lapatinib ditosylate monohydrate
Treatment of patients with HER2 overexpressing breast cancer in combination with: Capecitabine, for treatment of patients with advanced or metastatic breast cancer who have progressed on prior trastuzumab therapy in the metastatic setting, HR+ mets BC
Novartis Pharmaceuticals